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Downregulation of STRA6 Expression in Epidermal
Keratinocytes Leads to Hyperproliferation-Associated
Differentiation in Both In Vitro and In Vivo Skin
Models
Claudia Skazik1,5, Philipp M. Amann1,5, Ruth Heise1, Yvonne Marquardt1, Katharina Czaja1, Arianna Kim2,
Ralph Ru¨hl3, Peter Kurschat4, Hans F. Merk1, David R. Bickers2 and Jens M. Baron1
Retinoids are known to affect skin cell proliferation and differentiation and are key molecules that target retinoid
and retinoic acid receptors (RXRs and RARs), leading to physiological and pharmacologic effects. Our aim was to
elucidate the role of the retinol-binding protein receptor STRA6, mediating cellular uptake of retinol, on skin
structure and function. Our results indicate that STRA6 is constitutively expressed in human epidermal
keratinocytes and dermal fibroblasts and is regulated via RAR/RXR-mediated pathways. HaCaT (Human adult
low Calcium high Temperature) cells with stable STRA6 knockdown (STRA6KD) showed increased proliferation.
Consistently, human organotypic 3D skin models using stable STRA6KD HaCaT cells showed a significantly
thicker epidermis and enhanced expression of activation, differentiation, and proliferation markers. The effects
were reversible after treatment with free retinol. Human skin reconstitution employing STRA6KD HaCaT cells
leads to massive epithelial thickening under in vivo conditions in SCID mice. We propose that STRA6KD could
lead to cellular vitamin A deficiency in keratinocytes. Consequently, STRA6 has a role for regulating retinoid
homeostasis and in helping to program signaling that drives proliferation and differentiation of human skin cells.
By its influence on hyperproliferation-associated differentiation, STRA6 could also have a role in skin
regeneration and could be a target for pharmacological approaches to improve wound healing.
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INTRODUCTION
Vitamin A (all-trans retinol, atROL) and its biologically
active derivatives (retinoids) are important for maintaining
physiological processes, including regulation of growth and
development, and in skin barrier function (D’Ambrosio
et al., 2011). A wealth of data exist showing that retinoids
have critical regulatory functions in skin and influence
keratinocyte differentiation and skin homeostasis (Fisher and
Voorhees, 1996). The physiological effects of retinoids are
largely controlled by a family of nuclear ligand–dependent
retinoic acid receptors (RARa, RARb, and RARg) and retinoid
X receptors (RXRa, RXRb, and RXRg) (Amann et al., 2011).
Retinol-binding protein (RBP) is the principal physiological
carrier of retinol in the bloodstream for delivery to target
tissues (Wolf, 2007). The existence of a specific cell-surface
receptor on cells targeted by retinoids, mediating the uptake of
retinol from RBP, was described in the 1970s (Heller, 1975;
Bok and Heller, 1976; Rask and Peterson, 1976; Chen and
Heller, 1977). Since that time there has been increasing
evidence for the existence of a cell- and tissue-specific RBP
receptor (Sivaprasadarao and Findlay, 1994; Smeland et al.,
1995; Sundaram et al., 1998). Bouillet et al (1995) described
STRA6 (stimulated by retinoic acid gene 6) as an integral
transmembrane protein of unknown function that is inducible
by retinoic acid.
A breakthrough was achieved by Kawaguchi et al (2007)
who showed in bovine retinal epithelial cells that (i) RBP
can bind STRA6 with high affinity, (ii) STRA6-transfected
cells efficiently take up retinol, (iii) RNAi knockdown of
STRA6 suppresses retinol uptake, and (iv) STRA6 is
expressed in tissues consistent with its function as an RBP
receptor. These results provide strong evidence that STRA6
See related commentry on pg 1504 ORIGINAL ARTICLE
1Department of Dermatology and Allergology, University Hospital, RWTH
Aachen University, Aachen, Germany; 2Department of Dermatology, College
of Physicians and Surgeons, Columbia University, New York, New York, USA;
3Department of Biochemistry and Molecular Biology, University of Debrecen,
Debrecen, Hungary and 4Department of Dermatology, University Hospital of
Cologne, Cologne, Germany
Correspondence: Jens M. Baron, Department of Dermatology and Allergology,
University Hospital, RWTH Aachen University, Pauwelsstrae 30, D-52074
Aachen, Germany. Email: JensMalte.Baron@post.rwth-aachen.de
5These authors contributed equally to this work.
Received 2 April 2013; revised 11 October 2013; accepted 22 October 2013;
accepted article preview online 27 November 2013; published online 2
January 2014
Abbreviations: 9cisRA, 9-cis retinoic acid; 13cisRA, 13-cis retinoic acid; atRA,
all-trans retinoic acid; atROL, all-trans retinol; HaCaT, human adult low
calcium high temperature; Krt, keratin; LGD1069, targretin; NHEK, normal
human epidermal keratinocyte; NHDF, normal human dermal fibroblast; RAR,
retinoic acid receptor; RBP, retinol-binding protein; RXR, retinoid X receptor;
STRA6, stimulated by retinoic acid gene 6; STRA6KD, STRA6 knockdown
& 2014 The Society for Investigative Dermatology www.jidonline.org 1579
is a specific RBP receptor mediating the cellular uptake of
retinol.
Little is known about the physiological retinoid uptake
processes and how they mediate their effects on skin cells.
To determine the significance of STRA6 in skin, we analyzed
STRA6 expression and its regulation in human skin cells. To
approximate in vivo conditions we established an organotypic
human 3D skin model with stable STRA6KD HaCaT (Human
adult low Calcium high Temperature) keratinocytes and used
a human skin reconstitution model in mice to investigate the
influence of STRA6 on the structure and function of human
skin.
RESULTS
STRA6 is constitutively expressed in human skin cells
We could show that various human skin cells constitutively
express STRA6 mRNA (Figure 1a and b). By using quantitative
real-time (qRT) PCR analysis, we could demonstrate signifi-
cantly higher STRA6 mRNA levels in normal human epider-
mal keratinocytes (NHEKs), HaCaT cells, and in normal
human dermal fibroblasts (NHDFs) compared with the expres-
sion in primary human melanocytes.
STRA6 mRNA and protein expression increases after stimulation
with atRA in the murine keratinocyte cell line PAM212
To determine whether STRA6 is also upregulated in skin cells
after stimulation with atRA we treated PAM212 cells with
different concentrations of atRA (10 6, 10 7, or 108 M)
for 24 hours. STRA6 mRNA expression increased in a dose-
dependent manner after stimulation with atRA compared with
untreated cells (Figure 1c). atRA also led to upregulation of
STRA6 protein expression, which was confirmed by quantita-
tive evaluation (Figure 1d).
STRA6 mRNA expression increases after stimulation with ligands
of the nuclear retinoid acid receptors in NHEKs and NHDFs
To determine which signaling pathways mediate STRA6 gene
expression, we examined the effects of different ligands of the
nuclear retinoid receptor on STRA6 expression in NHEKs
(Figure 2a) and NHDF (Supplementary Figure S1a online).
Cells were stimulated with atRA, 9-cis retinoic acid (9cisRA),
13-cis retinoic acid (13cisRA), and atROL as prototypic
endogenous retinoids (ligands of RAR) and with targretin
(LGD1069) as the ligand of RXR, in comparison with ligands
of other class II nuclear receptors—phenobarbital, dexametha-
sone, and benzanthracene—at a concentration of 106 and
10 7 M for 4, 8, and 24 hours. We observed a time-dependent
strong increase in STRA6 mRNA expression after stimulation
with RAR ligands in the NHEKs of three separate donors
(Figure 2a). Similar results were obtained after stimulation of
NHDFs but with lesser upregulation of STRA6 mRNA expres-
sion (Supplementary Figure S1a online). Furthermore, treat-
ment with ligands of other class II nuclear receptors had no
effect on Stra6 mRNA expression.
STRA6 mRNA expression decreases after incubation with LE540,
an RAR panantagonist
Next, we blocked retinoid signaling using the RAR pananta-
gonist LE540 (Umemiya et al., 1997) after stimulation with the
RAR ligands. Retinoid-stimulated STRA6 mRNA expression is
significantly downregulated after treatment with LE540 in
NHEKs (Figure 2b) and NHDFs (Supplementary Figure S1b
online), verifying that STRA6 mRNA expression is likely
mediated by RAR.
Proliferation is enhanced in stable STRA6KD HaCaT cells
To assess the influence of STRA6 on the structure and function
of human skin cells we established a lentiviral-stable STRA6KD
in HaCaT cells. STRA6 mRNA expression in STRA6KD cells
was reduced up to 96% (clone K1) and compared with
untreated HaCaT cells. STRA6KD cells showed significantly
enhanced proliferation. Proliferation of both STRA6KD clones
K1 and K2 on day 7 correlated with STRA6 knockdown
efficiency (Figure 3a, Supplementary Figure S2 online).
To further study the proliferative capacity of STRA6KD cells
we performed an in vitro scratch assay. In STRA6KD cells (K1)
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Figure 1. STRA6 is constitutively expressed in skin cells and regulated by all-trans retinoic acid (atRA). (a, b) TaqMan real-time PCR analysis of Stra6 mRNA
expression in different human skin cells, primary human melanocytes (PHM), normal human epidermal keratinocytes (NHEK), human adult low calcium high
temperature (HaCaT) cells, and normal human dermal fibroblasts (HDF), was performed. qRT–PCR products were separated on 1.8% agarose gel and stained with
ethidium bromide. Values of ***Po0.001 were considered significant. (c, d) Stra6 mRNA expression increased in the murine keratinocyte cell line PAM212 after
the addition of atRA at various concentrations (106, 107, or 108 M) for 24 hours. TaqMan real-time PCR analysis was performed (c). Stra6 protein expression
increased after atRA stimulation in the murine keratinocyte cell line PAM212. Western blot was performed and quantified b-actin was used as loading control (d).
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there was marked acceleration in the rate of closure of the
scratch wound as compared with control cells. After 8 hours
the gap wasB60% closed in the STRA6KD cells as compared
with 16–30% in the control cells (Figure 3b, A1–B1). Immuno-
fluorescence DAPI staining revealed increased numbers of
nuclei by closure of the scratch of STRA6KD cells as
compared with control cells (Figure 3b, A2–B2). STRA6KD
cells showed enhanced expression of keratin 16 (Krt16), a
known proliferation marker in keratinocytes (Korge et al.,
1990; Patel et al., 2006) (Figure 3b, A3–B3). These findings
confirmed that the observed effects on gap closure were
preferentially due to enhanced cell proliferation and not due
to any augmentation in migration.
Human 3D skin equivalents constituted with STRA6KD HaCaT
cells showed thicker epidermis and enhanced expression of
proliferation, activation, and differentiation markers
To further assess the proliferative effects of STRA6KD on
morphological structure and function in a complex cell
system, we established an organotypic 3D skin model using
STRA6KD cells (K1) and HaCaT control cells (Figure 4a). The
epidermis of the STRA6KD 3D skin model displayed a
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Figure 2. Regulation of Stra6 expression in normal human epidermal keratinocytes (NHEKs). (a) NHEKs of three independent donors were stimulated with
different ligands of retinoic acid receptor (RAR) and ligands of other class II nuclear receptors at a concentration of 10 6 and 10 7 M for 4, 8, and 24 hours.
Untreated cells were used as control. TaqMan real-time PCR analysis was performed. (b) NHEKs of two independent donors were stimulated with different ligands
of RAR at a concentration of 106 M and LE540, a RAR panantagonist, at a concentration of 2.5mM for 24 hours. Untreated cells and cells treated only with LE540
were used as control. Values of **Po0.01 and ***Po0.001 were considered significant.
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significantly thicker epidermis (2.3-fold after 7 days and up to
2.7-fold after 14 days) (Figure 4a, A1–D1; Figure 4b, A1–B1)
and immunofluorescence DAPI staining revealed greater cell
density in the STRA6KD 3D skin (Figure 4a, A2–D2) as
compared with control cells. The cell proliferation marker
Krt16 was slightly upregulated in the STRA6KD 3D model
after 7 days and even more so after 14 days (up to 18-fold)
(Figure 4a, A3–D3, Figure 4b, A2–B2). In addition, the
keratinocyte activation marker Krt6 (Freedberg et al., 2001)
was significantly upregulated (sevenfold after 7 days and up to
threefold after 14 days) in the STRA6KD 3D model (Figure 4a,
A4–D4; Figure 4b, A3–B3). Expression of the keratinocyte
differentiation marker Krt10 (Kopan and Fuchs, 1989;
Freedberg et al., 2001) was significantly increased in
STRA6KD cells (6.8-fold after 7 days and up to 4.3-fold after
14 days) (Figure 4a, A5-D5; Figure 4b, A4–B4). As indicated
by Ki67 staining, STRA6KD K1 showed a stronger, and
atypically not restricted to the basal layer, proliferation after
7 days. However, Ki67 expression in the higher epidermal
layer could not be detected in the 14-day-old STRA6KD
model (Figure 4a, A6–D6).
Similar effects on proliferation and differentiation were
shown in the 3D model with STRA6KD HaCaT clone K2.
Probably because of reduced STRA6 knockdown efficiency in
K2 the observed effects were to a lesser extent (Supplementary
Figure S3 online).
Human skin reconstitution with STRA6KD HaCaT cells leads to
massive acanthotic epithelial thickening in vivo
A skin reconstitution assay was utilized according to the cell-
sorted skin equivalent (CeSSE, Figure 5a) model in SCID mice
as described by Wang et al. (2000), with some modifications.
Transplanted control HaCaT cells developed a regular
stratified epithelium consisting of 8–12 layers of keratinocytes
that exhibited normal differentiation features with a prominent
stratum granulosum and orthokeratosis (Figure 5b). In contrast,
transplanted STRA6KD HaCaT cells resulted in a disorganized,
highly acanthotic epidermis with 420 cell layers and elon-
gated rete ridges with corresponding lengthened dermal
papillae (Figure 5c). Furthermore, we observed a massive
parakeratotic stratum corneum covering the exophytic pro-
truding epithelium.
Effects of STRA6KD in human 3D skin equivalents are
diminished after incubation with free (RBP-unbound) atROL
To determine whether the proliferative behavior of STRA6KD
cells relates to retinol deficiency we performed a retinol
rescue experiment with the organotypic STRA6KD 3D model.
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Figure 3. Proliferation is highly upregulated in stable STRA6KD HaCaT cells. (a) Proliferation of stable STRA6KD cells K1 and K2 and of control cells transduced
with non-target vector was measured using AlamarBlue from day 1 to day 7. Values of **Po0.01, and ***Po0.001 were considered significant. (b) Scratch
assay: culture inserts (IBIDI) were placed in chamber slides and 1.4 105 cells were seeded in each chamber of the inserts. The culture inserts were removed when
cells were confluent, leading to a cell-free gap of B500mm. After 8 hours the experiment was completed and immunofluorescence staining of DAPI and
Krt16 was performed. Scale bar: 6 mm¼200mm.
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First, in vitro uptake assays were performed to verify that
HaCaT control and STRA6KD cells are capable of retinol
uptake. As expected, both types of cells were able to take up
similar amounts of free (RBP-unbound) atROL in a time-
dependent manner (Figure 6a). If the observed effects on skin
morphology are mediated by a STRA6KD-induced retinol
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Figure 4. Human HaCaT 3D skin equivalents with STRA6KD showed thicker epidermis and strongly enhanced expression of proliferation, activation, and
differentiation markers. (a) 3D skin models using STRA6KD cells (A, C)) and HaCaT control cells (B, D) were established and harvested after 7 days or 14 days.
Immunofluorescence examination of DAPI (A2–D2), Krt16 (A3–D3), Krt6 (A4–D4), Krt10 (A5–D5), and Ki67 (A6–D6) was performed. Scale bar: 9 mm¼ 100mm.
(b) Epidermal thickness (A1–B1) was measured and data were presented as mean epidermis thickness in mm. For Krt16 (A2–B2), Krt6 (A3–B3), and Krt10 (A4–B4)
three slides were determined for STRA6KD and control models. Data are presented as x-fold to the control. Values of **Po0.01, and ***Po0.001 were considered
significant.
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deficiency, the addition of retinol should rescue the cells.
Indeed, incubation with free atROL at a concentration of 10 6
and 107 M leads to reduced epidermal thickness as com-
pared with the untreated STRA6KD 3D model (Figure 6b,
A1–D1, A3–D3). Immunofluorescence staining revealed
downregulation of Krt16 in the atROL-treated STRA6KD
model (Figure 6b, A2–D2, A4–D4). Whereas a slight reduction
in epidermal thickness was also seen in the 106 M atROL-
treated HaCaT control model, the control model treated with
‘more physiological levels’ of atROL (10 7 M) showed no
clear differences in epidermal thickness compared with the
untreated control model. A possible explanation is that, by
balancing the retinoid level in STRA6KD HaCaT cells by
addition of free atROL, skin development and differentiation
normalizes in 3D skin equivalents.
DISCUSSION
Retinoids are important regulators of skin cell proliferation and
differentiation and represent a class of drugs that are remark-
ably useful therapeutically (Niles, 2002; Wang et al., 2009).
Despite their undoubted importance, little is known about
physiological retinoid uptake processes in skin cells. This—to
our knowledge previously unreleased—report reveals STRA6
expression and its regulation in skin cells using stable
transfected STRA6KD cells. We showed that STRA6 is con-
stitutively expressed in skin cells such as NHEK, HaCaT, and
NHDF. Smeland et al (1995) previously showed that undiffer-
entiated human keratinocytes have the highest RBP-binding
activity among many tested cell types.
The hypothesis that STRA6 expression is driven by atRA is
supported by studies in other cell lines (Bouillet et al., 1997;
Szeto et al., 2001). Consistent with these findings, our results
indicate that STRA6 expression is upregulated after stimulation
with atRA in the murine keratinocyte cell line PAM212 in a
dose-dependent manner. Upregulation of STRA6 expression
by atRA may be expected to result in potentially excessive
cellular intake of atROL, leading to even higher atRA concen-
trations (Blaner, 2007). Recent cell culture studies have
addressed this issue and have shown that STRA6-expressing
cells, preloaded with atROL, release more atROL into the
culture medium than the cells that do not express STRA6, and
indicate that the flux of atROL between RBP and STRA6 is
bidirectional (Isken et al., 2008). In addition, atROL accumu-
lation depends on the presence of other cellular proteins such
as cellular retinol-binding protein and the enzyme lecithin/
retinol-acyl transferase, which catalyzes the esterification of
atROL (Isken et al., 2008; Kawaguchi et al., 2011; Amengual
et al., 2012; Kawaguchi et al., 2012).
In this study we show that STRA6 mRNA expression is
strongly upregulated in NHEK and NHDF in a time-dependent
manner by RAR ligands and is also slightly increased by the
RXR ligand targretin (Wu et al., 2002; Tooker et al., 2007).
Furthermore, LE540, a RAR panantagonist, diminished the
upregulation of STRA6 (Umemiya et al., 1997). These results
indicate that STRA6 expression in skin cells is mediated by
RAR/RXR-signaling pathways.
However, the data from in vivo measurements of STRA6
expression are partly contradictory. No changes in STRA6
expression were observed after retinoid treatment of chick
embryos (Reijntjes et al., 2010), and dietary retinoid defi-
ciency had no effect on STRA6 expression in mouse embryos
(Kim et al., 2008), whereas retinoid-deprived quail embryos do
show upregulation of STRA6 (Reijntjes et al., 2010). In human
skin biopsies STRA6 was only expressed at low mRNA levels
(Pasutto et al., 2007). We and others (D’Ambrosio et al., 2011)
speculate that control of STRA6 expression is regulated in a
tissue-specific manner at both the gene and protein levels, and
depends on the cellular context and the in vivo retinoid status.
Interestingly, there are greater differences in responses to
retinoids between keratinocytes in vitro and keratinocytes
in vivo. Paradoxically, retinoids often have effects in cultured
keratinocytes that are the opposite of those in keratinocytes
in vivo. Accordingly, we used both in vitro and in vivo
approaches in monolayer cell culture experiments, in organo-
typic 3D models, and in a mouse model to further define the
STRA6-mediated effects.
Figure 5. Human skin reconstitution in the cell-sorted skin equivalent (CeSSE) model in NOD/SCID mice. (a) Implantation of human skin cells in a silicon
chamber implanted on the back of a SCID mouse. Four weeks after cell implantation skin biopsies were taken. (b) Epidermis and upper dermis generated using
control HaCaT keratinocytes and fibroblasts. (c) Epidermis and upper dermis generated using STRA6KD HaCaT cells and fibroblasts.
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Figure 6. Effects of STRA6KD in human 3D HaCaT skin equivalents are reversed after incubation with all-trans retinol (atROL). (a) HaCaT control cells and
STRA6KD cells were exposed to radiolabeled free atROL. After incubation for 30 or 60 minutes, the radioactive medium was removed, and cells were washed and
lysed by adding scintillation fluid. The cell-associated radioactivity was determined. The values are expressed as counts per minute and differences between cells
were not significant (NS). (b) After lifting the skin equivalent to the air–liquid interphase, atROL was added every 48 hours at a concentration of 106 or 107 M.
STRA6KD and HaCaT control 3D models without atROL treatment were used as control. 3D models were harvested after 7 days. Immunofluorescence
examination of Krt16 (A2–B2) was performed. Scale bar: 9 mm¼ 100mm
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Keratinocyte differentiation is marked by the expression of
differentiation-specific gene products. In human skin, epider-
mal differentiation occurs via two pathways. Under normal
conditions, differentiation is associated with the expression of
Krt1, Krt2, and Krt10. There are also additional pathways. For
example, differentiation in regenerative skin is associated with
increased expression of the hyperproliferation-associated Krt6
and Krt16 markers, whereas embryonic differentiation is
characterized by the expression of Krt4, Krt13, and Krt19
(Van Rossum et al., 2000). Under normal conditions, Krt13
expression is limited to non-keratinizing squamous epithelia
and its expression in skin is, together with the expression of
keratins Krt4 and Krt19, assumed to be a sign of reinduction of
embryonic differentiation (Van Rossum et al., 2000).
Previous studies revealed a strong correlation between Krt6
and Krt16 expression and epidermal hyperproliferation that
occurs in skin diseases such as psoriasis and actinic keratosis
(Stoler et al., 1988). Recently, upregulation of Krt6 and Krt16
was shown in cancer stem cells of squamous cell carcinoma
(Schober and Fuchs, 2011). In vitro studies of retinoids in
keratinocytes have shown that they inhibit cell proliferation
(Popadic et al., 2008) and decrease the expression of
differentiation-associated proteins such as Krt10 and several
other gene products associated with the formation of the
epidermal barrier (Fisher and Voorhees, 1996; To¨rma¨, 2011).
Lee et al. (2009) found that the differentiation marker Krt10
and the proliferation marker Krt16 are suppressed in
keratinocytes after treatment with atRA. Downregulation of
Krt6 and Krt16 was also observed after atRA treatment in
cultured skin sebocytes (Zouboulis et al., 1991). Conversely,
in the absence of atROL or its derivatives, terminal
differentiation of keratinocytes is enhanced (To¨rma¨ and
Vahlquist, 1984). One possible explanation may be that
keratinocyte differentiation and keratinization in the skin
relates to a functional vitamin A deficiency in the upper
layers of the epidermis. The observation that differentiated
keratinocytes downregulate the RBP receptor is consistent
with such a regulation of differentiation (Smeland et al., 1995).
If we assume that STRA6KD leads to cellular retinol deficiency
because of disturbed retinol influx, similar effects of retinoid
deficiency on differentiation and proliferation might occur.
Indeed, STRA6KD HaCaT cells manifest substantially
increased proliferation as confirmed by Krt16 upregulation
in monolayer experiments. Consistently, human organotypic
3D skin models using stable transduced STRA6KD HaCaT
cells showed a significantly thicker epidermis and enhanced
expression of activation, differentiation, and proliferation
markers (e.g. Krt6, Krt10, Krt16 and Ki67). As mentioned
above, the hyperproliferation-associated keratins Krt6 and
Krt16 are involved in the differentiation of regenerative skin
(Van Rossum et al., 2000). Krt6 and Krt16 are upregulated in
keratinocytes at the wound edge within 2–6 hours after injury
to normal epidermis and other stratified epithelia (Wawersik
and Coulombe, 2000). Transgenic mouse skin keratinocytes
express human Krt16 at steady-state levels approaching those
of endogenous Krt14 and display defects in cell–substratum
adhesion, differentiation, and migration but not in their ability
to proliferate. In addition, overexpression of human Krt16 has
been shown to delay the closure of full-thickness skin wounds
in vivo (Wawersik et al., 2001). Because of its role in
alternative hyperproliferation-associated differentiation (Van
Rossum et al., 2000) STRA6 could also have a role in skin
regeneration and could be a target for pharmacological
approaches to improve wound healing.
In contrast, retinoids enhance keratinocyte growth in vivo
but do not suppress keratinocyte terminal differentiation
(Fisher and Voorhees, 1996). To approximate in vivo condi-
tions we used a reconstituted skin model in a SCID/NOD
mouse model. Knocking down STRA6 in keratinocytes
resulted in a massively acanthotic epithelium. The epidermal
thickening was accompanied by a lack of differentiation with
a loss of the granular layer and prominent hyperparakeratosis.
These observations support our in vitro data that the STRA6
loss in keratinocytes results in increased proliferation and
reduced differentiation. Future studies should ascertain
whether hyperproliferative skin diseases such as psoriasis are
associated with decreased expression of STRA6 in keratino-
cytes. In addition, the conditional complete knockdown of
STRA6 in keratinocytes by using, for example, the Cre-loxP-
system may be useful for generating animal models for skin
diseases characterized by marked acanthosis, such as psoriasis
vulgaris.
AtROL is a small lipophilic molecule that can penetrate
biological membranes by passive non-ionic diffusion. As
expected, both HaCaT control and STRA6KD cells are capable
of free atROL uptake in a time-dependent manner. In a rescue
experiment we showed that atROL treatment leads to reduced
epidermal thickness in the STRA6KD 3D skin model. An
atROL-induced downregulation and normalization of Krt16
expression was shown in the STRA6KD 3D skin model at a
similar level to the atROL-treated or untreated HaCaT control
model. These results provide evidence that the effects of
STRA6KD in human 3D skin equivalents can be diminished
after treatment with free atROL.
We propose that STRA6KD causes cellular vitamin A
deficiency because of disturbed retinol influx. Consequently,
the RBP receptor STRA6 is essential for retinoid supply to
maintain retinoid homeostasis and to balance physiological
regulatory effects on the proliferation and differentiation of
human skin cells. How the mechanisms of retinoid home-
ostasis are mediated in detail, and to what extent the RBP
receptor STRA6 is involved, is not understood completely yet.
Nevertheless, it is obvious that the steady-state system of
intracellular retinoids is regulated by a complex feedback
control system involving the regulation of retinoid influx and
efflux that is important for skin homeostasis.
MATERIALS AND METHODS
Cell culture and skin equivalents
Isolation and culturing of NHEK, NHDF, and the keratinocyte cell
line HaCaT were performed as described elsewere (Heise et al., 2006;
Amann et al., 2012). Engineering of cocultures mainly leaned toward
the publication of Schoop et al (1999). In brief, NHDFs were seeded
into collagen gels, and, the following day, cells were plated onto the
fibroblast-collagen matrix. After 2 days, skin equivalents were lifted to
the air–liquid interphase and cultured over a period of 7 or 14 days.
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For rescue experiments, atROL (10 6 or 10 7 M) was added every
48 hours after lifting the skin equivalent to the air–liquid interphase.
Stable STRA6 knockdown (STRA6KD) in HaCaT cells
HaCaT cells were transduced with MISSION Lentiviral Transduction
particles with the following clone IDs: TRCN0000128299 (clone K1),
TRCN0000130376 (clone K2), and TRCN0000129158 (clone K3)
(Sigma, Taufkirchen, Germany).
Control cells were transduced with non-target ctrl particles
(SHC002V) (Sigma, Taufkirchen, Germany). Stable shRNA–express-
ing cells were generated by 2 weeks of bulk selection in Puromycin
(0.5mg ml 1)-containing growth medium.
RNA isolation and qRT–PCR
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Purified RNA was reversed transcribed with the High Capacity
RNA-to-cDNA Master Mix (Applied Biosystems, Weiterstadt, Germany).
TaqMan experiments were carried out on an ABI Prism 7000 seq-
uence detection system (Applied Biosystems, Weiterstadt, Germany)
using Assays-on-Demand gene expression products for human STRA6
(Hs00223621_m1) and mouse Mm00486457_m1 according to
the manufacturer’s recommendations. An Assay-on-Demand
product for human HPRT (Hs99999909_m1) and mouse GAPDH
(Mm99999915_g1) was used as an internal reference to normalize the
target transcripts.
Western blot
Cells were lysed using an MSE Soniprep150 sonicator and denatured
by suspension in Laemmli buffer containing 5% mercaptoethanol.
Western blot was performed according to the method described by
Schiffer et al (2003). The primary antibodies used were STRA6 anti-
mouse antibody (EB07811; Everest Biotech, Upper Heyford, UK) and
b-actin anti-mouse antibody (A5441; Sigma, Taufkirchen, Germany).
Detection was performed using horseradish peroxidase–conjugated
anti-goat or anti-mouse antibody (Dako, Glostrup, Denmark) and the
ECL kit (Amersham, Arlington Heights, IL).
In vivo human skin reconstitution assay in SCID mice
Human skin reconstitution assay was performed according to the CeSSE
model as previously described, with modifications (Wang et al., 2000).
Briefly, after anesthetizing the mice (n¼ 9), a circular 1-cm-
diameter sample of upper back skin was removed. The brim and
hat of the silicon chamber (CRD culture chambers, Renner, Dann-
stadt, Germany) were placed under the edge of the skin around the
perimeter of the surgical wound incision. The mixed STRA6KD
HaCaT/fibroblast or HaCaT control/fibroblast cell suspension contain-
ing 5 106 cells of each cell type was transferred into the chamber.
After 1 week the silicone chamber was removed and the wound was
allowed to dry for 3 additional weeks before biopsies were taken.
Reconstituted skin samples were fixed in 4% formalin and embedded
in paraffin. Sections measuring 4mm in thickness were stained with
hematoxylin and eosin.
Cellular retinol uptake assay
STRA6KD cells or HaCaT control cells were seeded in 24-well plates
and cultured up to 70% confluency. Subsequently, the cells were
exposed to radiolabeled atROL (2mCiml 1) (Perkin Elmer, Boston, MA).
After incubation for 30 or 60minutes, the radioactive medium was
removed, cells were washed with PBS, and lysed by adding Optiphase
‘‘Supermix’’ (Wallac, Turku, Finland) as scintillation fluid. The cell-
associated radioactivity was determined by transferring the lysate into a
flexible 24-well plate and counting radioactivity using a Wallac 1450
MicroBeta TriLux liquid scintillation counter (Wallac, Turku, Finland).
The values are expressed as counts per minute. The median values of
three independent experiments in triplicate were used for statistical data
analysis.
Proliferation assay
Cells (5 103) were plated in 24-well plates. Proliferation was
assayed over 1 week using the alamarBlue reagent (AbD Serotec,
Du¨sseldorf, Germany) according to the manufacturer’s protocol.
Scratch assay with STRA6KD cells
Culture inserts (IBIDI, Martinsried, Germany) were placed in chamber
slides, and 1.4 105 cells were seeded in each chamber of the
inserts. The culture inserts were removed when cells reached
confluence, leading to a cell-free gap of B500mm.
Light microscopy and immunofluorescence
For light microscopy and immunofluorescence 4-mm cryosections
were processed as described previously (Neis et al., 2010). Primary
antibodies (Krt6, Santa Cruz Biotechnology, Santa Cruz, California;
Krt10, Dako, Glostrup, Denmark; Krt16, AbD Serotec, Du¨sseldorf,
Germany; DAPI, Applichem, Darmstadt, Germany; Ki67, Dako,
Glostrup, Denmark) and fluorochrome-conjugated secondary anti-
body Alexa Fluor 488/546 (Molecular Probes, Eugene, Oregon) were
used. Relative quantification of Krt6, Krt10, and Krt16 expression in
3D skin equivalents was evaluated with the fluorescence imaging
software cell F (Olympus, Hamburg, Germany).
Statistical analysis
Data are given as arithmetical means±SEM. The given P-values were
compared with control. One-way ANOVA with Tukey’s multiple
comparison test or the unpaired T-test was performed with Sigmaplot
Version 11 (Erkrath, Germany). Values of *Po0.05, **Po0.01, and
***Po0.001 were considered significant and are indicated in the
figures.
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